Cytobin Tab 60mcg 60 mcg Tablet is a Health Canada–registered veterinary drug (DIN 00318647) held by Norden Laboratories Inc., containing Liothyronine Sodium. Health Canada lists its status as Cancelled Post Market (status date 10 Sep 1996). Nexara Health has matched 105 registrations of Liothyronine Sodium across 11 other regulated markets.

Health Canada registration

Liothyronine Sodium registered in other markets

105 registrations of the same molecule in 11 national registries outside Canada (first 35 shown, exact strength and form first). Each row is taken from the regulator's own published list; status is shown as the registry reports it.

See every manufacturer of Liothyronine Sodium worldwide →

Regulator price references for Liothyronine Sodium

Published list or reimbursement prices for Liothyronine Sodium presentations, in local currency, as at the date each registry last published. These are public reference prices, not Nexara Health quotes; strength and pack differ by row.

Sourcing through Nexara Health

Nexara Health is a Health Canada–licensed wholesaler (DEL #3-002896) in Winnipeg. This DIN is not currently marketed in Canada. The registrations above show which regulated markets hold an equivalent presentation that can be sourced for clinical comparator use or on a named-patient basis under Health Canada's Special Access Programme. Request a quote or read how named-patient and foreign-pack supply works in Canada.

Frequently asked questions

Is Cytobin Tab 60mcg (DIN 00318647) marketed in Canada?

No. Health Canada lists DIN 00318647 as Cancelled Post Market as of 10 Sep 1996.

Who holds the Canadian licence for this product?

Norden Laboratories Inc. is the company of record in the Health Canada Drug Product Database.

Is Liothyronine Sodium registered outside Canada?

Yes — Nexara Health has matched 105 registrations in 11 other markets (see the table above).

Where does this data come from?

Health Canada Drug Product Database (DPD), DIN 00318647, status date 1996-09-10; national medicine registries: DoH SEP database, EU national register, FDA NDC, Laegemiddelstyrelsen, Lyfjastofnun lyfjaverdskra, Medicines Authority, MoH deltio timwn, NHS dm+d VMP, PBS, TFDA, TITCK; price sources: DoH SEP database, Lyfjastofnun lyfjaverdskra, MoH deltio timwn, PBS. Nexara Health re-checks these sources weekly and shows the last verification date at the top of the page.

Source: Health Canada Drug Product Database (DPD), DIN 00318647, status date 1996-09-10; national medicine registries: DoH SEP database, EU national register, FDA NDC, Laegemiddelstyrelsen, Lyfjastofnun lyfjaverdskra, Medicines Authority, MoH deltio timwn, NHS dm+d VMP, PBS, TFDA, TITCK; price sources: DoH SEP database, Lyfjastofnun lyfjaverdskra, MoH deltio timwn, PBS.

Health Canada Drug Product Database (DPD), DIN 00318647, status date 1996-09-10; national medicine registries: DoH SEP database, EU national register, FDA NDC, Laegemiddelstyrelsen, Lyfjastofnun lyfjaverdskra, Medicines Authority, MoH deltio timwn, NHS dm+d VMP, PBS, TFDA, TITCK; price sources: DoH SEP database, Lyfjastofnun lyfjaverdskra, MoH deltio timwn, PBS. Last reviewed 2026-09-17. Nexara Health is a licensed wholesaler and supplies licensed entities only; consumer orders are routed to a partner pharmacy.